IP Library Granted Patent US 9,433,708
Granted Patent B2
US 9,433,708 · App. 14/216,020 · Granted Sep 6, 2016

Intravenous connector having antimicrobial treatment

Inventor: Patrick E. Eddy (Allendale, MI)
A61L29/16A61L29/06A61M39/26A61L2300/208A61L2300/404A61M2039/267
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,433,708
App. No.
14/216,020
Granted
Sep 6, 2016
Kind
B2
Abstract

An intravenous connector is provided having a valve body having first end configured to receive a syringe for administering medicine to a patient; a spike element having a tapered hollow spike terminating in a tip at a first end and having a second end configured for attaching to an intravenous tube, the spike element secured in the valve body such that the tip is disposed proximate the first end of the valve body and the second end of the spike element is located at a second end of the valve body; and a pliable seal member disposed in the valve body around the tapered hollow spike and exposed at the first end of the valve body. An antimicrobial material comprising a silane quaternary ammonium salt is incorporated on or within the seal member and is coated on the valve body and the spike element.

Claims (26)

1. An intravenous connector comprising:

a valve body having an open first end configured to receive a syringe for administering medicine to a patient; and

a silicone seal member disposed in said valve body and exposed at the open first end of said valve body configured to receive the syringe,

wherein an antimicrobial material is incorporated on or within said silicone seal member and is coated on said valve body, and

wherein said antimicrobial material comprises a silane quaternary ammonium salt.

2. The intravenous connector of claim 1 , further comprising:

a spike element having a tapered hollow spike terminating in a tip at a first end and having a second end configured for attaching to an intravenous tube, said spike element secured in said valve body such that said tip is disposed proximate the first end of said valve body and the second end of said spike element is located at a second end of said valve body opposite the first end of said valve body,

wherein said antimicrobial material is coated on said spike element.

3. The intravenous connector of claim 1 , wherein said silane quaternary ammonium salt includes an organofunctional silane covalently bonded to said valve body.

4. The intravenous connector of claim 1 , wherein said silane quaternary ammonium salt comprises 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride.

5. The intravenous connector of claim 1 , wherein said antimicrobial treatment is applied to said valve body as an antimicrobial treatment solution comprising said silane quaternary ammonium salt and isopropyl alcohol.

6. The intravenous connector of claim 5 , wherein the antimicrobial treatment solution comprises about 30 percent to about 50 percent by volume of isopropyl alcohol at the time of application to said valve body.

7. The intravenous connector of claim 5 , wherein the antimicrobial treatment solution comprises about 50 percent to about 70 percent by volume of the antimicrobial treatment substance at the time of application to said valve body.

8. The intravenous connector of claim 1 , wherein said antimicrobial treatment is substantially free from arsenic, silver, tin, heavy metals and polychlorinated phenols.

9. The intravenous connector of claim 1 , wherein said antimicrobial treatment is incorporated within said silicone seal member by mixing said antimicrobial treatment into a silicone slurry used to form said silicone seal member.

10. An intravenous connector comprising:

a valve body having an open first end configured to receive a syringe for administering medicine to a patient, and a second end opposite the first end; and

a spike element having a tapered hollow spike terminating in a tip at a first end and having a second end configured for attaching to an intravenous tube, said spike element secured in said valve body such that said tip is disposed proximate the first end of said valve body and the second end of said spike element is located at the second end of said valve body,

a pliable seal member disposed in said valve body around said tapered hollow spike and exposed at the open first end of said valve body configured to receive the syringe,

wherein an antimicrobial material is incorporated on or within said seal member and is coated on said valve body and said spike element, and

wherein said antimicrobial material comprises a silane quaternary ammonium salt.

11. The intravenous connector of claim 10 , wherein said silane quaternary ammonium salt includes an organofunctional silane covalently bonded to said valve body and said spike element.

12. The intravenous connector of claim 10 , wherein said silane quaternary ammonium salt comprises 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride.

13. The intravenous connector of claim 10 , wherein said antimicrobial treatment is applied to said valve body and said spike element as an antimicrobial treatment solution comprising said silane quaternary ammonium salt and isopropyl alcohol.

14. The intravenous connector of claim 10 , wherein said antimicrobial treatment is substantially free from arsenic, silver, tin, heavy metals and polychlorinated phenols.

15. The intravenous connector of claim 10 , wherein said pliable seal member is a silicone seal member, and said antimicrobial treatment is incorporated within said silicone seal member by mixing said antimicrobial treatment into a silicone slurry used to form said silicone seal member.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2016
From: EDDY, PATRICK E.
To: PARASOL MEDICAL LLC
Reel/Frame 039392/0607 →
Continuity (2)
Provisional Application 61786930 · Mar 15, 2013
Related Publication 20140276456A1 · Sep 18, 2014